Abstract 7360: Pre-Existing Anemia and Short-Term Outcomes in Cardiogenic Shock: A Propensity-Matched Cohort Study
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.7360 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Ishmum Chowdhury und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Anemia is prevalent among patients with cardiovascular disease and is independently associated with adverse outcomes in acute coronary syndromes and heart failure. Prior studies linking hemoglobin to outcomes in cardiogenic shock (CS) have measured hemoglobin during the acute hospitalization, when values may be confounded by fluid resuscitation, hemodilution, and procedural blood loss. Whether hemoglobin measured before shock onset independently predicts outcomes remains incompletely characterized.
Methods
We conducted a retrospective cohort study using the TriNetX Global Collaborative Network, a federated electronic health record database. Adults hospitalized with CS and concomitant vasoactive medication use were identified between January 2016 and December 2025. Baseline hemoglobin was defined as the most recent value obtained 7-28 days prior to the index CS event and stratified by a prespecified threshold of ≤10.9 g/dL versus ≥11.0 g/dL, consistent with WHO moderate-to-severe anemia classification. Patients with prior CS within two years, major bleeding, transfusion, or dialysis dependence were excluded. 1:1 propensity score matching balanced demographics, comorbidities, laboratory values, and medication exposures. The primary outcome was 30-day all-cause mortality; secondary outcomes included mechanical circulatory support (MCS), renal replacement therapy (RRT), mechanical ventilation, stroke or TIA, readmission, and cardiac arrest. Urinary tract infection served as a falsification endpoint.
Results
Among 10,399 eligible patients, 2,955 had hemoglobin ≤10.9 g/dL and 7,444 had hemoglobin ≥11.0 g/dL. After 1:1 propensity score matching, 2,556 patients remained per cohort. Lower pre-shock hemoglobin was associated with higher 30-day all-cause mortality (HR 1.16, 95% CI 1.06-1.28; p=0.002). Anemic patients were less likely to receive MCS (HR 0.58; p
Zitieren
APA
Chowdhury, I., Chi, K. Y., Lee, P., Mangalesh, S., Morgan, A., Rossi, R., Babapour, G., Nouri, A., Akman, Z., Damluji, A. A., & Nanna, M. (2026). Abstract 7360: Pre-Existing Anemia and Short-Term Outcomes in Cardiogenic Shock: A Propensity-Matched Cohort Study. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7360
Vancouver
Chowdhury I, Chi KY, Lee P, Mangalesh S, Morgan A, Rossi R, et al. Abstract 7360: Pre-Existing Anemia and Short-Term Outcomes in Cardiogenic Shock: A Propensity-Matched Cohort Study. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7360
BibTeX
@article{Chowdhury2026,
author = {Chowdhury, Ishmum and Chi, Kuan Yu and Lee, Pei-Lun and Mangalesh, Sridhar and Morgan, Ahmed and Rossi, Raiza and Babapour, Golsa and Nouri, Armin and Akman, Zafer and Damluji, Abdulla A and Nanna, Michael},
title = {Abstract 7360: Pre-Existing Anemia and Short-Term Outcomes in Cardiogenic Shock: A Propensity-Matched Cohort Study},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.7360}
}
EUVIMED